The Mail & Guardian4d
The endgame to HIV/Aids
The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...
Clinical Trials Arena on MSN5d
Gilead to launch Phase III once-yearly HIV PrEP trial after Phase I success
Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...
‘I have a deal for him’: Head of UNAIDS offers deal to President Trump to end AIDS
Head of UNAIDS, Winnie Byanyima, speaks to Bianna Golodryga about the impact of USAID funding cuts to the global fight ...